[Federal Register Volume 86, Number 218 (Tuesday, November 16, 2021)]
[Notices]
[Pages 63394-63395]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24989]



[[Page 63394]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-22-1046]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled National Breast and Cervical Cancer Early 
Detection Program (NBCCEDP) Monitoring Activities to the Office of 
Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on July 26, 2021 to obtain comments from the 
public and affected agencies. CDC received one non-substantive comment 
related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) Monitoring Activities--(OMB Control No. 0920-1046, Exp. 11/
30/2021)--Revision--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    CDC is requesting a Revision of the Information Collection Request 
(ICR) titled National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP) Monitoring Activities (OMB Control No. 0920-1046). In 
the previous OMB approval period, information collection consisted of 
an annual NBCCEDP survey and clinic-level data collection. In the next 
OMB approval period, information collection will consist of a revised 
NBCCEDP survey, revised clinic-level data collection, new quarterly 
program update, new service delivery projection worksheet, and the 
addition of previously approved minimum data elements (MDEs; OMB 
Control No. 0920-0571, Exp. 03/31/2022) to increase efficiency. The 
number of respondents will remain the same and the total estimated 
annualized burden will increase from 683 to 1,228.
    Breast and cervical cancers are prevalent among U.S. women. 
Evidence shows that deaths from both breast and cervical cancers can be 
avoided by increasing screening services--mammography and pap tests--
among women. However, screening is typically underutilized among women 
who are under- or uninsured, have no regular source of healthcare, or 
who recently immigrated to the U.S. To improve access to cancer 
screening, Congress passed the Breast and Cervical Cancer Mortality 
Prevention Act of 1990 (Pub. L. 106-354) which directed CDC to create 
the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP). The NBCCEDP currently provides funding to 70 awardees under 
``Cancer Prevention and Control Programs for State, Territorial, and 
Tribal Organizations (DP17-1701).'' The purpose of NBCCEDP is to 
increase breast and cervical cancer screening rates among women 
residing within defined geographical locations (as determined by the 
funded program) who are at or below 250% of the federal poverty level; 
aged 40-64 years for breast cancer services, and aged 21-64 years for 
cervical cancer services; and under- or uninsured.
    In 2022, CDC will issue a new Notice of Funding Opportunity (DP22-
2202) to continue this mission. Consistent with programmatic changes, 
the information collection plan has also been redesigned to update 
existing and add new data collection instruments and integrate the 
previously approved MDEs into this single approval package to increase 
efficiency of information collection for the NBCCEDP.
    CDC proposes five forms of information collection. First, the 
NBCCEDP Survey will be submitted to CDC annually and collects 
information to monitor awardees' TA needs, partnerships, screening 
delivery, EBI implementation, and COVID-19 impact. Minor revisions to 
survey questions, response options, and formatting will be included 
under DP22-2202. Second, clinic-level data will be submitted to CDC at 
baseline and annually for all partnering health system clinic sites--an 
estimated six clinics per awardee for breast cancer data and six 
clinics per awardee for cervical cancer data. Clinic-level data 
includes health system, clinic, and patient population characteristics; 
monitoring and quality improvement activities; EBI implementation; 
COVID-19 impact, and baseline or annual screening rates. Minor 
revisions were made to variable wording, formatting (e.g., split or 
combined variables), and response options to improve data quality. 
Third, the Quarterly Program Update (QPU) will be submitted to CDC four 
times per year to monitor award spending, service delivery, staff 
vacancies, and program accomplishments and challenges. This is a new 
information collection. Fourth, the Service Delivery Projection 
Worksheet will be submitted to CDC annually to report the estimated 
number of women to be served for breast and cervical cancer. Finally, 
the Minimum Data Elements (MDEs) will be submitted to CDC twice per 
year to monitor patient demographics; breast and cervical cancer 
screening, diagnosis, and treatment; timeliness of services; and 
patient navigation. This information collection was previously approved 
(OMB Control No. 0920-0571, Exp. 03/30/2022) and will now be 
incorporated into this OMB approved package for increased efficiency 
for NBCCEDP information collection efforts.

[[Page 63395]]

    This revised information collection will allow CDC to provide 
routine monitoring feedback to awardees based on their data 
submissions, tailor technical assistance (TA) as needed, support 
program planning, and assess program outcomes. OMB approval is 
requested for three years. Participation is required for NBCCEDP 
awardees. There are no costs to respondents other than their time. The 
total estimated annual burden is 1,228 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
         Type of respondent                   Form name              Number of     responses per   per response
                                                                    respondents     respondent       (in hrs)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees...................  Annual NBCCEDP Survey......              70               1           56/60
                                     NBCCEDP Clinic-level                     70               6           45/60
                                      Information Collection
                                      Instrument--Breast.
                                     NBCCEDP Clinic-level                     70               6           45/60
                                      Information Collection
                                      Instrument--Cervical.
                                     Quarterly Program Update...              70               4           32/60
                                     Service Delivery Projection              70               1           29/60
                                      Worksheet.
                                     MDEs.......................              70               2          150/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-24989 Filed 11-15-21; 8:45 am]
BILLING CODE 4163-18-P